Nimorazole: Difference between revisions
(Created page with "{{Drugbox | verifiedrevid = 444760513 | IUPAC_name = 4-[2-(5-nitro-1''H''-imidazol-1-yl)ethyl]morpholine | image = Nimorazol.png <!--Clinical data--> | tradename = | Drugs....") |
No edit summary |
||
| Line 48: | Line 48: | ||
| StdInChIKey = MDJFHRLTPRPZLY-UHFFFAOYSA-N | | StdInChIKey = MDJFHRLTPRPZLY-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Nimorazole''' ([[International Nonproprietary Name|INN]]) is a [[nitroimidazole]] [[anti-infective]].<ref>{{cite pmid|1098732}}</ref> It is also being investigated for the treatment of [[head and neck cancer]].<ref>{{cite pmid|12559522}}</ref><ref>{{ClinicalTrialsGov|NCT01507467|IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck}}</ref> | '''Nimorazole''' ([[International Nonproprietary Name|INN]]) is a [[nitroimidazole]] [[anti-infective]].<ref>{{cite pmid|1098732}}</ref> It is also being investigated for the treatment of [[head and neck cancer]].<ref>{{cite pmid|12559522}}</ref><ref>{{ClinicalTrialsGov|NCT01507467|IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck}}</ref> | ||
==References== | ==References== | ||
{{reflist | {{reflist|2}} | ||
[[Category:Nitroimidazole antibiotics]] | [[Category:Nitroimidazole antibiotics]] | ||
[[Category:Antiprotozoal agents]] | [[Category:Antiprotozoal agents]] | ||
[[Category:Morpholines]] | [[Category:Morpholines]] | ||
[[Category:Drug]] | |||
Revision as of 14:25, 9 April 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C9H14N4O3 |
| Molar mass | 226.23 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
|
WikiDoc Resources for Nimorazole |
|
Articles |
|---|
|
Most recent articles on Nimorazole |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Nimorazole at Clinical Trials.gov Clinical Trials on Nimorazole at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Nimorazole
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Nimorazole Discussion groups on Nimorazole Patient Handouts on Nimorazole Directions to Hospitals Treating Nimorazole Risk calculators and risk factors for Nimorazole
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Nimorazole |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nimorazole (INN) is a nitroimidazole anti-infective.[1] It is also being investigated for the treatment of head and neck cancer.[2][3]
References
- ↑ PMID 1098732 (PMID 1098732)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 12559522 (PMID 12559522)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov
- Pages with script errors
- Pages with incomplete PMID references
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Nitroimidazole antibiotics
- Antiprotozoal agents
- Morpholines
- Drug